The Canadian Prospective Cohort Study to understand progression in multiple sclerosis: baseline characteristics.

ABSTRACT:

Background

Disease progression is observed across the spectrum of people with multiple sclerosis (MS) and identification of effective treatment strategies to halt progression remains one of the greatest unmet clinical needs.

Objectives

The Canadian Prospective Cohort Study to Understand Progression in MS (CanProCo) was designed to evaluate a wide range of factors associated with the onset and rate of clinical disease progression in MS and to describe the interplay between these factors.

Design

A prospective cohort study.

Methods

CanProCo is a national, prospective, observational cohort study that has recruited 944 individuals from 5 large academic MS centers in Canada. Participants include people with radiologically isolated syndrome (RIS), early relapsing-remi

SUBMITTER: Oh J 

PROVIDER: S-EPMC11402083 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature